期刊文献+

当前肿瘤基因治疗中存在的主要问题及其解决途径 被引量:5

Major Problems and Their Solutions in Current Tumor Gene Therapy
下载PDF
导出
摘要 本文概述了当前肿瘤基因治疗研究中存在的一些主要问题 ,如绝大多数治疗方案中目的基因只有一个 ,肿瘤基因治疗缺乏靶向性 ,基因转移载体的效率、安全性及容量等问题。讨论了解决这些问题的主要途径 ,即肿瘤多基因联合治疗、直接体内途径基因治疗与靶向基因治疗、基因转移载体的改造。 There are three major problems in the research of current tumor gene therapy.First,only one aim gene is adopted in most gene therapy schemes.Second,being short of transition target,tumor gene therapy is deficient.Third,gene transfer vectors have some defects,such as efficiency,safety,capacity limit etc.The solutions to these problems are combination gene therapy,in vivo gene therapy or targeted gene therapy,and gene transfer vectors reforming.\;
出处 《生物工程进展》 CSCD 2000年第4期72-74,71,共4页 Progress in Biotechnology
关键词 肿瘤基因治疗 多基因联合治疗 靶向基因治疗 Tumor gene therapy\ Combination gene therapy\ Targeted gene therapy\ Gene transfer vectors reforming
  • 相关文献

参考文献4

二级参考文献4

共引文献18

同被引文献45

  • 1谢英,叶丽亚,张小滨,侯新朴,娄晋宁.血脑屏障体外实验模型的建立[J].北京大学学报(医学版),2004,36(4):435-438. 被引量:16
  • 2尹冰楠,李冬田,李秋香,佟惠春,李光明.高效化学转化菌内同源重组法构建重组腺病毒[J].天津医药,2005,33(7):437-440. 被引量:3
  • 3张景迎,王运坤.肿瘤基因治疗的可能途径[J].泰山医学院学报,1995,16(4):366-368. 被引量:1
  • 4Biezinger P, Wang J J, Gondo M, et al .Systemic inhibition of tumor growth and tumor metastases by intramuscular administration of the endostatin gene. Nature Biotechnology, 1999, 17:343-8.
  • 5Feldman AL, Restifo NP, Alexander HR, et al .Antiangiogenic gene therapy of cancer utilizing recombinant adenovirus to elevate systemic endostatin levels in mice.Cancer Res, 2000, 60(6) : 1503- 6.
  • 6O' Reilly MS, Boehm T, Shing Y, et al .Endostatin: An Endogenous Inhibitor of Angiogenesis and Tumor Growth. Cell,1997,88: 277- 85.
  • 7Mullen CA, Coale MM, Lowe T, et al .Tumors expressing the cytosine deaminase suicide gene can be eliminated in vivo with 5-fluorocytocine and induce protective immunity to wild typetumor.Cancer Res, 1994,54(3) : 1503-6.
  • 8Hoganson DK, Batra RK, Olsen JC, et al .Comparison of the effects of three differenttoxin genes and their levels of expression on cell growth and by-stander effect in lung adenocarcinoma.Cancer Res, 1996, 56(6) : 1316- 23.
  • 9Li Y, Yu DC,Chen Y, et al .A hepatocellular carcinoma-specificadeno virus variant, CV890, eliminates distant human liver tumors in combination with daxorubiven .Cancer Res, 2001, 61:6428-36.
  • 10He TC, Zhou S, Luis T, et al .A simplified system for generating recombinant adenoviruses .Pric Natl Acad Sci USA, 1998,95 : 2509- 14.

引证文献5

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部